How Chimera Investment’s New Q4 Dividend Declaration Will Impact Chimera Investment (CIM) Investors

• Chimera Investment Corporation’s board declared a fourth-quarter cash dividend of US$0.37 per common share, payable on January 30, 2026, to shareholders of record as of the December 31, 2025 ex-dividend date.
• This dividend decision sheds light on Chimera’s ongoing approach to distributing income from its diversified mortgage asset portfolio, a key focus for income-oriented investors.
• We’ll now explore how this latest dividend declaration shapes Chimera Investment’s broader investment narrative and informs expectations around future income stability.

The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

Chimera Investment Investment Narrative Recap

To own Chimera Investment, you need to be comfortable with a mortgage REIT that leans on leverage and complex credit assets to generate distributable income. The fresh US$0.37 fourth quarter dividend supports Chimera’s income story, but does not materially change the near term tension between maintaining that payout and the risk that funding costs or credit losses could pressure earnings and book value.

The recent Q3 2025 results, showing a small net loss after prior profitability, are particularly relevant here because they frame this dividend decision against a backdrop of uneven earnings. For income focused investors, that combination of a high payout and patchy profitability puts extra attention on how Chimera manages its short term repo funding and interest rate exposure in the coming quarters.

Yet behind the attractive cash yield, investors should be aware that Chimera’s reliance on short term repo funding and floating rate liabilities...

Read the full narrative on Chimera Investment (it's free!)

Chimera Investment's narrative projects $382.2 million revenue and $168.2 million earnings by 2028.

Uncover how Chimera Investment's forecasts yield a $14.50 fair value, a 12% upside to its current price.

Exploring Other Perspectives

Six fair value estimates from the Simply Wall St Community span roughly US$11.36 to US$16 per share, showing how widely views can differ. When you set those opinions against Chimera’s reliance on short term repo funding and floating rate liabilities, it underlines why many investors look at both upside potential and balance sheet risk before forming a view.

Explore 6 other fair value estimates on Chimera Investment - why the stock might be worth as much as 23% more than the current price!

Build Your Own Chimera Investment Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Chimera Investment research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.
• Our free Chimera Investment research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Chimera Investment's overall financial health at a glance.

Ready For A Different Approach?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• We've found 13 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
• Explore 28 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• AI is about to change healthcare. These 29 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com